<div class="article">
	<h3>Duramed Pharmaceuticals Inc.</h3>
	<div class="article-info">
		<ul>
			<li>Author: Author Unknown</li>
			<li>Date: 05/30/90</li>
		</ul>
	</div>
	<p class="article-leader">CINCINNATI -- Duramed Pharmaceuticals Inc. said it signed
a joint-venture agreement with Atral/Cipan, giving Duramed
the U.S. marketing rights to the Lisbon, Portugal-based
antibiotics maker's drugs that have been approved by the U.S.
Food and Drug Administration, including Amoxicillin,
Cephalexin and Tetracycline. Terms weren't disclosed.</p>
	<div class="article-body"><p></p></div>
</div>
